Viking Therapeutics, Inc. (0VQA) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Day and welcome to the Viking Therapeutics Second Quarter twenty twenty six Financial Results Conference Call. At this time, all participants are in a listen only mode. Following management's prepared remarks, we will hold a Q and A session. And as a reminder, this conference call is being recorded today, 07/29/2026. I would now like to turn the conference over to Viking's Manager of Investor Relations, Stephanie Diaz. Please go ahead, Hello, and thank you all for participating in today's call. Joining me today is Brian Lian, Viking's President and CEO and Greg Santee, Viking's CFO. Before we begin, I'd like to caution that comments made during this conference call today, 07/29/2026, will contain forward looking statements under the Safe Harbor provisions of The U. S. Private Securities Litigation Reform Act of 1995, including statements about Viking's expectations regarding its development activities, timelines and milestones. Forward looking statements are subject to risks and uncertainties that could cause actual results to differ materially and adversely and reported results should not be considered as an indication of future performance. These forward looking statements speak only as of today's date the company undertakes no obligation to revise or update any statement made today. I encourage you to review all of the company's filings with the Securities and Exchange Commission concerning these and other matters. I'll now turn the call over to Brian Lian for his initial comments. Thanks, Stephanie, and good afternoon to everyone listening in by phone or on the webcast. Today, we'll review our financial results for the second quarter and six months ended 06/30/2026, and review recent updates across our pipeline, programs and organization. During the second quarte...